Envista Holdings Co. (NYSE:NVST) Receives $20.18 Average PT from Analysts

Envista Holdings Co. (NYSE:NVST) has been given an average recommendation of “Hold” by the fifteen analysts that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $20.18.

A number of equities analysts have weighed in on NVST shares. Piper Sandler upped their price target on Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research report on Monday, February 3rd. Jefferies Financial Group upped their price target on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. JPMorgan Chase & Co. reduced their price target on Envista from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, March 6th. UBS Group cut their price objective on Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a report on Monday, March 10th. Finally, Wells Fargo & Company set a $19.00 price objective on Envista in a report on Saturday, March 8th.

Envista Stock Performance

Shares of NVST stock opened at $17.16 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76. The stock has a 50-day moving average of $19.94 and a 200-day moving average of $19.64. Envista has a one year low of $15.15 and a one year high of $23.00. The stock has a market cap of $2.95 billion, a PE ratio of -2.64, a price-to-earnings-growth ratio of 1.27 and a beta of 1.33.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. As a group, sell-side analysts expect that Envista will post 1 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Huntington National Bank boosted its stake in Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after buying an additional 949 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in Envista by 528.4% in the fourth quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after buying an additional 1,638 shares in the last quarter. GAMMA Investing LLC boosted its stake in Envista by 30.5% in the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock valued at $44,000 after buying an additional 538 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Envista in the fourth quarter valued at about $53,000. Finally, Mitsubishi UFJ Trust & Banking Corp acquired a new stake in Envista in the fourth quarter valued at about $86,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.